BACKGROUND: Acute, peripheral and central administration of recombinant rat interleukin-1beta (IL-1beta) has been shown to decrease social exploration and locomotor activity and to induce alterations in brain biogenic amines in rats. The aims of this study were to examine whether acute, repeated and chronic administration of IL-1beta to rats may interfere with shuttle box escape learning, a model for anxiety- and depression-like behavior. METHODS: Sixty-four adult male viral-free Sprague-Dawley rats (200-300 g weight) housed in groups of four at 25 degrees C with a 12:12 light:dark cycle were used in the experiments. They were divided into 8 groups, i.e. 4 control and 4 experimental. The latter were divided into an acute group receiving a single intra-peritoneally (i.p.) challenge of IL-1beta (tested at the shuttle box 1 and 24 h later); a chronic group with daily i.p. injections of IL-1beta for 7 days (tested at the shuttle box 1 h later); and a group with repeated administration, i.e. one i.p. injection on the first day and a second challenge on the seventh day (tested at the shuttle box 1 h later). The control animals followed the same injecting and testing schedule but were treated i.p. with saline. RESULTS: The acute group treated with one IL-1beta challenge and tested 1 (P=0.001) and 24 h (P=0.002) later showed significant time elongations in the escape trials. The animals treated chronically with IL-1beta for seven consecutive days showed a significant increase in the latency at the escape trials (P=0.0001). Repeated administration of IL-1beta on the first day and a second on the seventh day did not significantly alter the time elongation in the escape trial. DISCUSSION: Acute and chronic administration of IL-1beta significantly increase the latency of escape to a foot shock, whereas repeated IL-1beta administration does not induce a sensitization of these behavioral responses.
BACKGROUND: Acute, peripheral and central administration of recombinant ratinterleukin-1beta (IL-1beta) has been shown to decrease social exploration and locomotor activity and to induce alterations in brain biogenic amines in rats. The aims of this study were to examine whether acute, repeated and chronic administration of IL-1beta to rats may interfere with shuttle box escape learning, a model for anxiety- and depression-like behavior. METHODS: Sixty-four adult male viral-free Sprague-Dawley rats (200-300 g weight) housed in groups of four at 25 degrees C with a 12:12 light:dark cycle were used in the experiments. They were divided into 8 groups, i.e. 4 control and 4 experimental. The latter were divided into an acute group receiving a single intra-peritoneally (i.p.) challenge of IL-1beta (tested at the shuttle box 1 and 24 h later); a chronic group with daily i.p. injections of IL-1beta for 7 days (tested at the shuttle box 1 h later); and a group with repeated administration, i.e. one i.p. injection on the first day and a second challenge on the seventh day (tested at the shuttle box 1 h later). The control animals followed the same injecting and testing schedule but were treated i.p. with saline. RESULTS: The acute group treated with one IL-1beta challenge and tested 1 (P=0.001) and 24 h (P=0.002) later showed significant time elongations in the escape trials. The animals treated chronically with IL-1beta for seven consecutive days showed a significant increase in the latency at the escape trials (P=0.0001). Repeated administration of IL-1beta on the first day and a second on the seventh day did not significantly alter the time elongation in the escape trial. DISCUSSION: Acute and chronic administration of IL-1beta significantly increase the latency of escape to a foot shock, whereas repeated IL-1beta administration does not induce a sensitization of these behavioral responses.
Authors: Helen C Fox; Carrol D'Sa; Anne Kimmerling; Kristen M Siedlarz; Keri L Tuit; Raymond Stowe; Rajita Sinha Journal: Hum Psychopharmacol Date: 2012-03 Impact factor: 1.672
Authors: George R Breese; Darin J Knapp; David H Overstreet; Montserrat Navarro; Tiffany A Wills; Robert A Angel Journal: Neuropsychopharmacology Date: 2007-06-06 Impact factor: 7.853